There appears to be more bad news for Merck & Co. after a Canadian Medical Association Journal said the drug may raise the risk of heart attack for patients who took Vioxx for less than 2 weeks. Investigative journalist Evelyn Pringle reports that the study published online this month, found that more than 25% of 239 patients who had heart attacks did so in less than 13 days of being on the drug. 

New reports indicate that patients that took the drug may have a higher risk of death for years after taking the drug. A Reuters reports quotes Curt Furberg, a member of the US Food and Drug Administration’s Drug Safety and Risk Management Advisory Committee, It may be that Vioxx is causing permanent damage to the cardiovascular system, accelerating atherosclerosis or a sustained increase in blood pressure.”

Furberg, a professor of public health at Wake Forest University, said his stroke concerns stem from a new 107-page report on patients who were followed for a year after they stopped taking Vioxx.

The dangers caused by Vioxx may begin early and may last long after use is stopped. Joe Neel of NPR says the risk of heart attacks, strokes and serious peripheral vascular disorders began to increase soon after people started taking 25 mg of Vioxx each day. It is unclear whether the 50mg dose was more or less dangerous than the 25mg dose.

Neel adds that the risk is difficult to determine because Merck & Co. has not released all of the data that were collected in the study, known by its acronym APPROVe (Adenomatous Polyp PRevention on Vioxx).

Merck disputes the new claims and disagrees with the interpretation. The company says that their APPROVe data show that cardiovascular problems occurred in patients who took Vioxx longer than 18 months.

Neel says there are several conditions that have been associated with Vioxx use. These problems include serious strokes, so-called “mini-strokes” (also known as transient ischemic attacks), heart attacks, angina, congestive heart failure, coronary artery disease, phlebitis and other serious blockages of veins.



We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

Merck to pay $830 million to settle investors’ Vioxx...

Merck announced Friday it will pay $830 million to settle investor complaints accusing it of committing...

Merck to pay nearly $1 billion for illegal marketing...

American pharmaceutical company Merck, Sharp & Dohme has agreed to pay $950 million to resolve criminal...

Merck paying more than 3,100 vioxx death claims

Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who...

Settlement limits insurers' claims in Vioxx deal

TRENTON, N.J. (AP) -- Former Vioxx users getting part of a $4.85 billion settlement ending most personal...

Persistence pays in Vioxx litigation

Plaintiffs get close to $5B, but Merck could have done a lot worse. Attorneys who spent nearly one year...

Vioxx settlement payments to begin in August

Merck & Co., manufacturer of Vioxx, announced it will make the first payment of $500 million on Aug....

Impressed with the Beasley Allen staff

I am very impressed with the Beasley Allen staff. They were very courteous and patiently explained the aspects of my claim in a way I could understand. If I ever have any need of an attorney in the future I will turn to Beasley Allen.

—Philip